FAQs
Q1. What is Desonide and how does it rank among topical corticosteroids?
A1. Desonide is a non-halogenated, mild-potency topical corticosteroid (Class VI in the US potency classification — one of the weakest classes, with Class VII being weakest). Being non-halogenated means it lacks the fluorine or chlorine atoms present in stronger steroids like Betamethasone or Mometasone, which significantly reduces its risk of causing skin atrophy with correct use. It acts by binding to intracellular glucocorticoid receptors, inhibiting NF-κB signalling and phospholipase A2 — reducing the cascade of pro-inflammatory cytokines, prostaglandins, and leukotrienes responsible for redness, swelling, and itching in inflammatory skin conditions. Available only on prescription; use strictly as directed by your dermatologist.
Q2. What skin conditions is Desowen Cream prescribed to treat?
A2. Desowen Cream (Desonide) is prescribed for mild to moderate inflammatory skin conditions including atopic dermatitis (eczema), contact dermatitis, allergic dermatitis, seborrheic dermatitis, and mild plaque psoriasis on the body. Its low potency and favourable safety profile make it particularly suitable for conditions on the face, eyelids, and skin folds (axillae, groin, inframammary) where stronger corticosteroids carry a significant risk of skin thinning. It is not intended for fungal, bacterial, or viral skin infections, which require specific antimicrobial treatment.
Q3. Why is Desonide safer for use on the face and sensitive skin areas compared to stronger corticosteroids?
A3. Stronger halogenated corticosteroids (Betamethasone, Clobetasol, Fluocinolone) carry well-documented risks of skin atrophy, visible telangiectasia, striae (stretch marks), perioral dermatitis, and steroid-induced acne when used on thin, delicate facial and intertriginous skin — risks that accumulate with duration of use. Desonide's non-halogenated, low-potency profile means it produces the anti-inflammatory relief needed for mild facial eczema or eyelid dermatitis with substantially reduced risk of these complications. This is why dermatologists often specifically prescribe Desowen Cream for the face, eyelids, or skin folds where stronger alternatives would be inappropriate.
Q4. How should Desowen Cream be applied correctly?
A4. Wash and gently pat the affected area dry before application. Apply a thin layer — a pea-sized amount covers a 10 cm² area — to the affected skin only, not to surrounding normal skin. Gently rub in until absorbed. Do not cover with airtight (occlusive) dressings unless specifically directed by your dermatologist, as occlusion significantly increases steroid absorption and risk. Use exactly as long as prescribed — typically short courses of one to two weeks for acute flares — rather than applying continuously as a long-term moisturiser. Wash hands after application unless hands are the treated area.
Q5. What are the risks of prolonged use of Desowen Cream, even at its low potency?
A5. Even low-potency corticosteroids carry risks with prolonged or unsupervised use. Extended daily application can cause local skin thinning (atrophy), increased visibility of blood vessels, hypopigmentation on darker skin tones, and reduced efficacy over time (tachyphylaxis). On the face, long-term topical steroid use can cause perioral dermatitis or topical steroid withdrawal reactions when stopped abruptly after extended use. Never self-extend a corticosteroid prescription beyond the prescribed duration. Your dermatologist can assess whether ongoing treatment is needed and can recommend non-steroid maintenance options (such as calcineurin inhibitors like Pimecrolimus) for long-term management of eczema.
